Difference between revisions of "Team:Duke/Safety"

(Prototype team page)
 
Line 3: Line 3:
 
<h2>Safety in iGEM</h2>
 
<h2>Safety in iGEM</h2>
  
−
<p>Please visit <a href="https://2015.igem.org/Safety">the main Safety page</a> to find this year's safety requirements & deadlines, and to learn about safe & responsible research in iGEM.</p>
+
 
 +
Any long term applications in microbial populations within humans should place safety as the primary concern. As such, the cell death gene would need to be with minimized side effects on the patient. Further, the long term successful implementation would work on a largely population level, so the spread of the antibiotic detecting plasmid would be important to the overall phenotypic change away from antibiotic resistance. But particular care would be necessary to limit unwanted infection of synthetic plasmids into those who do not want the plasmid. Care should also be taken to avoid any pathogenicity that could arise from the added plasmid and cell death gene.
 +
 
 +
<!--<p>Please visit <a href="https://2015.igem.org/Safety">the main Safety page</a> to find this year's safety requirements & deadlines, and to learn about safe & responsible research in iGEM.</p>
  
 
<p>On this page of your wiki, you should write about how you are addressing any safety issues in your project. The wiki is a place where you can <strong>go beyond the questions on the safety forms</strong>, and write about whatever safety topics are most interesting in your project. (You do not need to copy your safety forms onto this wiki page.)</p>
 
<p>On this page of your wiki, you should write about how you are addressing any safety issues in your project. The wiki is a place where you can <strong>go beyond the questions on the safety forms</strong>, and write about whatever safety topics are most interesting in your project. (You do not need to copy your safety forms onto this wiki page.)</p>
Line 25: Line 28:
 
<h4>Safe Shipment</h4>
 
<h4>Safe Shipment</h4>
  
−
<p>Did you face any safety problems in sending your DNA parts to the Registry? How did you solve those problems?</p>
+
<p>Did you face any safety problems in sending your DNA parts to the Registry? How did you solve those problems?</p>-->
  
  
 
</div>
 
</div>
 
</html>
 
</html>

Revision as of 01:26, 19 September 2015



Safety in iGEM

Any long term applications in microbial populations within humans should place safety as the primary concern. As such, the cell death gene would need to be with minimized side effects on the patient. Further, the long term successful implementation would work on a largely population level, so the spread of the antibiotic detecting plasmid would be important to the overall phenotypic change away from antibiotic resistance. But particular care would be necessary to limit unwanted infection of synthetic plasmids into those who do not want the plasmid. Care should also be taken to avoid any pathogenicity that could arise from the added plasmid and cell death gene.